| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | Apr 8, 2025 | Viking Therapeutics, Inc. | Director | Buy | 91.3 | +1,240 | 100.00% | ✗ | $29.9K |
| Mar 31, 2025 | Apr 2, 2025 | Viking Therapeutics, Inc. | Director | Buy | 91.3 | +1,240 | 100.00% | ✗ | $29.9K |
| Oct 25, 2024 | Oct 25, 2024 | Viking Therapeutics, Inc. | Director | Sell | 7.5 | -11,000 | -100.00% | ✓ | $889.8K |
| Feb 8, 2024 | Feb 8, 2024 | Viking Therapeutics, Inc. | Director | Sell | 7.5 | -25,000 | -100.00% | ✓ | $701.3K |
| Jan 19, 2024 | Jan 19, 2024 | Viking Therapeutics, Inc. | Director | Sell | 7.5 | -30,000 | -100.00% | ✓ | $691.5K |